La saison a débuté
Johnson & Johnson Q1 Earnings:
Revenue: $20.69B (est $19.48B) -EPS: $2.17 -Sees FY Adj EPS: $7.50 To $7.90 -2020 Guidance Lowered To Reflect COVID-19 -Announces A $6.3% Dividend Boost To $1.01/Share From 95C (est $1)
https://www.cnbc.com/2020/04/14/jj-s...-outbreak.html
Johnson & Johnson Q1 Earnings:
Revenue: $20.69B (est $19.48B) -EPS: $2.17 -Sees FY Adj EPS: $7.50 To $7.90 -2020 Guidance Lowered To Reflect COVID-19 -Announces A $6.3% Dividend Boost To $1.01/Share From 95C (est $1)
https://www.cnbc.com/2020/04/14/jj-s...-outbreak.html
J&J raised its dividend from 95 cents a share to $1.01, a 6.3% increase. The company lowered its 2020 adjusted earnings forecast to between $7.50 and $7.90 earnings per share, from its prior estimate of between $8.95 and $9.10 a share.
The company beat Wall Street’s earnings and revenue expectations. On an adjusted basis, J&J reported $2.30 per share during the first three months of the year, higher than the $2 a share expected by Refinitiv analysts. It generated $20.7 billion in revenue, higher than the $19.47 billion expected.
The company beat Wall Street’s earnings and revenue expectations. On an adjusted basis, J&J reported $2.30 per share during the first three months of the year, higher than the $2 a share expected by Refinitiv analysts. It generated $20.7 billion in revenue, higher than the $19.47 billion expected.
Commentaire